1) Over the last 10 years, JCPS's annual revenue has risen from $1.25 billion in 2016 to $1.86 billion in 2025 while district ...
Senate Bill 19 would mandate intervention services for students scoring "limited" on state tests, but educators worry about ...
AtoZ Sports on MSN
Two of the Dolphins' biggest whiffs this season are aging horribly for Miami and Mike McDaniel's latest update made it even worse
The Miami Dolphins struck gold in free agency in 2024. The team landed tight end Jonnu Smith, who made the Pro Bowl while ...
Backed by Sam Altman, this nuclear fission startup has captured the market's imagination, rallying roughly 300% year-to-date on a single premise: AI needs baseload power. Wind and solar are ...
Chalkbeat on MSNOpinion
Pay teachers more, 311 for parents, move district boundaries: How Mamdani could improve NYC schools
Chalkbeat asked dozens of experts, students, parents, educators, and nonprofit leaders to share bold ideas for the incoming ...
24/7 Wall St. on MSN
3 dividend ETFs you haven’t heard of that yield over 5%
Quick Read Amplify Natural Resources Dividend Income ETF (NDIV) yields 5.72% monthly from 41 natural resource dividend stocks ...
We just feel like the door is being closed in front of us,” said Ryan Jenkins, economic development coordinator for Fairview Heights.
According to design plans from JHS Architecture presented to the Lexington-Richland 5 school board this month, the school ...
As 2025 draws to a close, MyHighPlains.com is taking a look back at what our team and our community consider the top stories of the past year, including significant stories regarding local ...
Yahoo Finance is chronicling the latest news and updates on President Trump's plans to impose tariffs on goods from other ...
New charter schools are struggling to enroll enough students to stay solvent. One High Point school’s implosion shows the consequences.
AstraZeneca and Daiichi Sankyo’s ENHERTU® (fam-trastuzumab deruxtecan-nxki) has been granted Breakthrough Therapy Designation (BTD) in the US for adult patients with HER2-positive early breast cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results